Brazil
- Capital: Brasillia
- Economy: World's 6th largest by nominal GDP. Nominal GDP US$2.492 trillion, 2012
- Health Expenditure: 8.4% of GDP, 2011
- Population: 211.5 million, 2017
- Average Life Span: 71.9 yrs, 2011
- Languages: Portugese
- Adult Literacy Rate: 88.6%
Health Trends
- Lifestyle diseases increasingly resemble those of the United States and Europe such as obesity, heart disease, and cancer which are on the rise in the major cities
- Although the disease profile is shifting, some typical developing country diseases can still be found in some areas
- Only about 25% of Brazilians have private health insurance
- Medical assistance is popular among companies, which allocate about 6% of payroll to healthcare
- Healthcare is free (public), however there are long waiting periods for procedures
- Shortages of doctors and hospitals in smaller cities
Clinical Trial Landscape
- Brazil is the 7th pharmaceutical market with sales of US$20 billion in 2011. The expectation is that the country will be the 6th largest market in 2015 according to IMS Health
- There is a wide range of ethnic influences: Portuguese, Spanish, Italian, German, and Japanese, making the country a large melting-pot and suitable for the study of many different diseases
- Population is very concentrated in the main cities, facilitating the access to patients, despite the size of the country
- Approximately half of the trials taking place in Brazil are manned by CROs and almost all of them are headquartered in Sao Paulo
- Brazil has its own CRO association called,“ABRACRO”, launched in 2006
- Top Therapeutic areas: oncology, diabetes, cardiovascular, rheumatology, infectious diseases, transplants, pulmonology, CNS and ophthalmology
- Hospitals within the cities are very large, some with 1000 beds so trials only need to have a few key hospitals signed up as sites
- The largest hospital in Latin America is in Sao Paulo (Hospital das Clinicas de Sao Paulo) with 2200 beds
- Experienced and highly motivated investigators. Many trained in US and Europe. Most speak English
- Advantage with the reversal of the seasons thus companies can test seasonally induced diseases
- There is a strong doctor-patient relationship which contributes to excellent enrollment and retention rates
ICON in Brazil |
Add to Comparison Tool |
- Established in Sao Paulo, Brazil in 2005
- 146 employees, 2017
- Majority of studies in Oncology, Cardiovascular, and Metabolics
- Awarded studies: 176 (1999 – YTD 2012). Oncology (44), CNS (20), Diabetes (19), Cardiovascular (14), Infectious Diseases (14), GI (12), Metabolics (6), Renal Transplant (8)
Services Offered
- Clinical Research
- Regulatory Affairs
- Late Phase and Outcomes Research
- Medical & Safety Services
- Quality Assurance
- DOCS Resourcing Solutions
- Functional Resourcing
- Flexible Resourcing
- Permanent Recruitment
Contact Us for further information